Quoin Pharmaceuticals, Ltd. - ADR earnings per share and revenue
On 06 nov 2025, QNRX reported earnings of -6.71 USD per share (EPS) for Q3 25, missing the estimate of -5.07 USD, resulting in a -32.19% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -11.19% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -3.40 USD, with revenue projected to reach -- USD, implying an reducir of -49.33% EPS, and -- of --% in Revenue from the last quarter.
Preguntas frecuentes
What were Quoin Pharmaceuticals, Ltd. - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Quoin Pharmaceuticals, Ltd. - ADR reported EPS of -$6.71, missing estimates by -32.19%, and revenue of $0.00, 0% as expectations.
How did the market react to Quoin Pharmaceuticals, Ltd. - ADR's Q3 2025 earnings?
The stock price moved down -11.19%, changed from $9.65 before the earnings release to $8.57 the day after.
When is Quoin Pharmaceuticals, Ltd. - ADR expected to report next?
The next earning report is scheduled for 11 mar 2026.
What are the forecasts for Quoin Pharmaceuticals, Ltd. - ADR's next earnings report?
Based on 5
analistas, Quoin Pharmaceuticals, Ltd. - ADR is expected to report EPS of -$3.40 and revenue of -- for Q4 2025.